Aptevo Therapeutics Inc. (NASDAQ: APVO) announced Jeff Lamothe has been appointed president and chief executive officer, while Marvin White transitioned ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE